Cancer metabolism is a rapidly evolving field that explores how cancer cells reprogram their energy production and consumption to support rapid growth and spread. Unlike healthy cells, cancer cells often rely on altered metabolic pathways that allow them to survive and thrive in low-oxygen or nutrient-poor environments. By understanding these unique metabolic shifts, scientists are identifying new opportunities to target cancer more effectively and precisely.

At the MCW Cancer Center, researchers use advanced technologies to measure metabolic activity in real time. By profiling a patient’s metabolites—such as sugars, lipids, proteins, and other small molecules—scientists observe how cancer cells respond to stress and other environmental factors. These metabolic “fingerprints” provide crucial insights into tumor behavior, even in the earliest stages of disease.

Metabolic profiling also helps reveal vulnerabilities in cancer cells. For example, some cancers depend heavily on specific metabolic pathways; disrupting these pathways can slow or halt tumor growth. This knowledge is driving the development of new drugs that attack the metabolic processes fueling cancer, offering more precise and potentially less toxic treatment options.

Beyond treatment, cancer metabolism research is improving diagnosis and monitoring. Scientists are exploring ways to track tumors using radiotracers that highlight cancer-specific metabolites, enabling more accurate imaging than traditional methods. This dual approach—visualizing and targeting cancer cells—enhances the ability to diagnose, monitor, and treat cancers, especially in sensitive areas like the brain, where regenerating cells are limited.